TY - JOUR
T1 - Transient visual disturbances in adolescents
T2 - Migrainous feature or headache-accompanied phenomenon?
AU - Liu, Hung Yu
AU - Fuh, Jong Ling
AU - Lu, Shiang Ru
AU - Chen, Shih Pin
AU - Chou, Chi Hsiang
AU - Wang, Yen Feng
AU - Wang, Shuu Jiun
N1 - Funding Information:
Dr S-J Wang has served on the advisory boards of Pfizer, Allergan, and Elli Lilly, Taiwan. He has received speaking honoraria from local companies (Taiwan branches) of Pfizer, Elli Lilly, Boehringer Ingelheim and GSK. He has received research grants from the Taiwan National Science Council, Taipei-Veterans General Hospital and Taiwan Headache Society. Dr J-L Fuh is a member of a scientific advisory board of Elli Lilly, and has as well received research support from the Taiwan National Science Council, Taipei-Veterans General Hospital and Elli Lilly.
Funding Information:
This study was supported in part by grants from Taiwan National Science Council (100-2314-B-010-019-MY2, 100-2314-B-010-018-MY3), Taipei-Veterans General Hospital (VGHUST101-G7-1-1, V101C-106, V101E7-003), NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 100-2911-I-008-001), Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan.
PY - 2012/11
Y1 - 2012/11
N2 - Objectives: To investigate the prevalence, characteristics and clinical correlates of transient visual disturbances (TVDs) in adolescents with headaches. Methods: We surveyed headache-related TVDs in the past three months in two middle schools. All the ninth-grade students filled-in the questionnaires including demographics, a validated headache questionnaire, and visual phenomenon questions embedding the Visual Aura Rating Scale (VARS). TVDs were defined as transient visual phenomena corresponding to a headache attack, but not visual aura, i.e. VARS ≥four. Results: Six hundred and sixty-three adolescents (341 boys and 322 girls; mean age 15.1±0.3 years old) participated in this study. In subjects reporting at least one headache during the past three months (N=371), 33.4% reported TVDs, which accounted for 18.7% in total participants. TVDs were described mainly as flickering lights or scotoma, movable, monochromatic, occurring over bilateral visual fields, developing and lasting ≥30 seconds, and experienced during the headache phase. Subjects with migraines reported a higher frequency of TVDs than those with non-migraine headaches (67.1% vs. 31.2%, p≥0.001). TVDs were independently associated with photophobia (OR12.6, p≥0.001) and pulsatile headache (OR=2.1, p=0.012).
AB - Objectives: To investigate the prevalence, characteristics and clinical correlates of transient visual disturbances (TVDs) in adolescents with headaches. Methods: We surveyed headache-related TVDs in the past three months in two middle schools. All the ninth-grade students filled-in the questionnaires including demographics, a validated headache questionnaire, and visual phenomenon questions embedding the Visual Aura Rating Scale (VARS). TVDs were defined as transient visual phenomena corresponding to a headache attack, but not visual aura, i.e. VARS ≥four. Results: Six hundred and sixty-three adolescents (341 boys and 322 girls; mean age 15.1±0.3 years old) participated in this study. In subjects reporting at least one headache during the past three months (N=371), 33.4% reported TVDs, which accounted for 18.7% in total participants. TVDs were described mainly as flickering lights or scotoma, movable, monochromatic, occurring over bilateral visual fields, developing and lasting ≥30 seconds, and experienced during the headache phase. Subjects with migraines reported a higher frequency of TVDs than those with non-migraine headaches (67.1% vs. 31.2%, p≥0.001). TVDs were independently associated with photophobia (OR12.6, p≥0.001) and pulsatile headache (OR=2.1, p=0.012).
KW - adolescents
KW - migraine
KW - photophobia
KW - Transient visual disturbances
KW - visual aura
UR - http://www.scopus.com/inward/record.url?scp=84868670831&partnerID=8YFLogxK
U2 - 10.1177/0333102412460777
DO - 10.1177/0333102412460777
M3 - Article
C2 - 22990689
AN - SCOPUS:84868670831
SN - 0333-1024
VL - 32
SP - 1109
EP - 1115
JO - Cephalalgia
JF - Cephalalgia
IS - 15
ER -